Lipo C is a compounded medication , not FDA-approved
What the FDA Has Said About BPC-157 and Compounding In September 2023, the FDA put BPC-157 in Category 2 of the 503A Interim Bulks Guidance, which stopped pharmacies from compounding it
GLP-1 manufacturers like Lilly or Novo Nordisk have set the list price for the drug at more than $1,000 a month
Yang Z, Lv Y, Yu M, Mei M, Xiang L, Zhao S, et al
Heartburn is not among the most frequently reported side effects in clinical trials, though related symptoms like dyspepsia occur in some patients
Your provider will design a personalized plan for you.